Britain's Prince Charles' food firm is launching a range of herbal remedies. The 60-year-old prince watched as the first batch of the new Duchy Originals herbal goods - which will be available in the new year - was made as he toured the factory and laboratories of the healthcare company who are producing the products.

Duchy Original's chief executive officer Andrew Baker said: "Duchy Original's decision to launch a range of herbal tinctures reflects the prince's passion for adopting an integrated approach to healthcare."

The Transportation Security Administration launched a $1.3 million advertising campaign designed to have air passengers accept stringent travel rules which have often served as sources of disagreement and annoyances at checkpoints.

The ad campaign was conceived after a passenger focus study made for TSA by business consulting company Blue Lime discovered passengers' unquestioning compliance with TSA rules has gone down. According to Blue Lime missing their trip is a greater concern now among American travelers than the threat of an attack on their plane.

His is a life imitating art, Hiroshi Nohara, of Japan has been living at the Terminal 1 of the Benito Juarez airport in Mexico City since arriving there on September 2 and he does not want to leave yet.

Reminiscent of the Tom Hanks and Catherine Zeta-Jones starrer, "The Terminal" where Hanks played to role of Viktor Navorski, a man from the fictional country of Krakozhia who arrived at the John F. Kennedy airport in New York only to find out that his country was overtaken by rebels mid-flight, invalidating his passport making him stateless and a fixture in the airport, Nahora has made Benito Juarez airport his "home."

Six students from Rice University in Houston are creating a beer than contains more of the red wine's healthy ingredients that help reduce the risk of heart disease and cancer.

The research team's leader, junior Taylor Stevenson, said they are using genetic engineering to create a beer with a higher resveratrol content.

Australian scientists from Sydney IVF, a fertility firm, got a license Wednesday to produce cloned human embryos.

It is Australia's and the world's first license to obtain stem cells from cloned human embryos. It is expected to generate controversy in medical research over ethical issues.